Essential narcotic drug rules clarified; licence possession limits set and permitted sales recipients expanded for manufacturers and medical institutions The amendment creates an exception in rule 43 for cessation-of-manufacture notices when cessation is due to unforeseen circumstances beyond the licencee's control; limits a manufacturer's possession of essential narcotic drugs to quantities specified in the applicable licence while exempting Government Opium Factories from limits; and replaces rule 52F(1) to enumerate permitted recipients of essential narcotic drugs sold otherwise than on prescription, including licensed manufacturers, licenced dealers, licenced chemists, registered medical practitioners, Controller-authorised persons, and recognized medical institutions.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Essential narcotic drug rules clarified; licence possession limits set and permitted sales recipients expanded for manufacturers and medical institutions
The amendment creates an exception in rule 43 for cessation-of-manufacture notices when cessation is due to unforeseen circumstances beyond the licencee's control; limits a manufacturer's possession of essential narcotic drugs to quantities specified in the applicable licence while exempting Government Opium Factories from limits; and replaces rule 52F(1) to enumerate permitted recipients of essential narcotic drugs sold otherwise than on prescription, including licensed manufacturers, licenced dealers, licenced chemists, registered medical practitioners, Controller-authorised persons, and recognized medical institutions.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
